North China Pharmacy does not sign agreement with Shanghai Fosun

The heyday of Chongqing built manufacturing base to deny the establishment of North China Pharmaceutical (600812) issued a clarification announcement, Hua Pharmaceutical group to introduce strategic collaborators has been in the process of negotiations, including with the Shanghai Fosun Group, the current Hua pharmaceutical group has not signed any written letter of intent or agreement with Shanghai Fosun Group.　　Recently reported that Hua Pharmaceutical group and Shanghai Fosun Group to discuss cooperation matters, the company relocation process some subordinate enterprises may be discontinued.　　According to the need of strategic development, China Pharmaceutical group has long been seeking to introduce strategic investors, aiming at diversifying equity, transforming the operating mechanism of enterprises, and introducing the capital needed for enterprise development. The announcement said that the company's production and operation of the normal stability, relocation and transformation is in accordance with the announcement plan to advance.　　Companies adhere to the unified advance, first built after the relocation, there is no new changes, there is no production caused by the relocation of the phenomenon.　　The heyday of Heavenly Creations (600335) announced that the company's holding subsidiaries peak Tiangong Construction Machinery Sales Co., Ltd. and Chongqing Qin Cattle Engineering Machinery Co., Ltd's cooperation only to marketing business-oriented business cooperation, no investment in Chongqing to establish a manufacturing base plan. Recently, media reports, the heyday of the Construction Machinery Co., Ltd. across the geographical boundaries, with a Chongqing company to invest 260 million yuan, in Chongqing to establish a wheel excavator manufacturing base. The announcement said there was no investment in the project by the company and its holding subsidiaries.